Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20981769rdf:typepubmed:Citationlld:pubmed
pubmed-article:20981769lifeskim:mentionsumls-concept:C0231170lld:lifeskim
pubmed-article:20981769lifeskim:mentionsumls-concept:C0013080lld:lifeskim
pubmed-article:20981769lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:20981769lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:20981769lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:20981769lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:20981769lifeskim:mentionsumls-concept:C1516691lld:lifeskim
pubmed-article:20981769pubmed:issue4lld:pubmed
pubmed-article:20981769pubmed:dateCreated2010-10-28lld:pubmed
pubmed-article:20981769pubmed:abstractTextTrisomy 21 (TRS21), also referred to as Down syndrome, occurs once in every 800-1,000 live births. It is the consequence of an extra copy of HSA21 that causes an imbalanced gene dose effect. TRS21 is the first known genetic cause of cognitive disability. The syndrome is complex, and includes various cardiac, immune, and bone disorders. Most of these signs are highly variable in expression but cognitive disability is the most constant characteristic of persons with TRS21. The syntenies that exist between HSA21 and three mouse chromosomes (MMU10, MMU16, and MMU17) offer the opportunity for a genotype-phenotype correlation. We present here the segmental trisomies available in the mouse and we discuss their contribution to the brain and cognitive phenotypes of TRS21.lld:pubmed
pubmed-article:20981769pubmed:languageenglld:pubmed
pubmed-article:20981769pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20981769pubmed:citationSubsetIMlld:pubmed
pubmed-article:20981769pubmed:statusMEDLINElld:pubmed
pubmed-article:20981769pubmed:monthNovlld:pubmed
pubmed-article:20981769pubmed:issn1552-4876lld:pubmed
pubmed-article:20981769pubmed:authorpubmed-author:RoubertouxPie...lld:pubmed
pubmed-article:20981769pubmed:authorpubmed-author:CarlierMichèl...lld:pubmed
pubmed-article:20981769pubmed:copyrightInfo© 2010 Wiley-Liss, Inc.lld:pubmed
pubmed-article:20981769pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20981769pubmed:day15lld:pubmed
pubmed-article:20981769pubmed:volume154Clld:pubmed
pubmed-article:20981769pubmed:ownerNLMlld:pubmed
pubmed-article:20981769pubmed:authorsCompleteYlld:pubmed
pubmed-article:20981769pubmed:pagination400-16lld:pubmed
pubmed-article:20981769pubmed:meshHeadingpubmed-meshheading:20981769...lld:pubmed
pubmed-article:20981769pubmed:meshHeadingpubmed-meshheading:20981769...lld:pubmed
pubmed-article:20981769pubmed:meshHeadingpubmed-meshheading:20981769...lld:pubmed
pubmed-article:20981769pubmed:meshHeadingpubmed-meshheading:20981769...lld:pubmed
pubmed-article:20981769pubmed:meshHeadingpubmed-meshheading:20981769...lld:pubmed
pubmed-article:20981769pubmed:meshHeadingpubmed-meshheading:20981769...lld:pubmed
pubmed-article:20981769pubmed:meshHeadingpubmed-meshheading:20981769...lld:pubmed
pubmed-article:20981769pubmed:meshHeadingpubmed-meshheading:20981769...lld:pubmed
pubmed-article:20981769pubmed:meshHeadingpubmed-meshheading:20981769...lld:pubmed
pubmed-article:20981769pubmed:year2010lld:pubmed
pubmed-article:20981769pubmed:articleTitleMouse models of cognitive disabilities in trisomy 21 (Down syndrome).lld:pubmed
pubmed-article:20981769pubmed:affiliationFaculty of medicine Aix Marseille University and INSERM. pierre.roubertoux@univmed.frlld:pubmed
pubmed-article:20981769pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20981769pubmed:publicationTypeReviewlld:pubmed
pubmed-article:20981769pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed